- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01240122
Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions
January 10, 2018 updated by: Abbott Medical Optics
An investigational multi-purpose solution (MPS)was clinically evaluated against Biotrue MPS at specific time points over the course of four days.
The study was conducted with PureVision lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Ana, California, United States, 92705
- Abbott Medical Optics Inc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- were at least 18 years old;
- were experienced contact lens wearers;
- were correctable to at least 20/40 or better in both eyes with contact lenses;
- were in good general health, with healthy eyes (other than requiring vision correction);
- had not worn lenses for at least 12 hours before each baseline visit;
- had a corneal staining score no greater than Grade 1 in either eye at time of enrollment;
- had previously used an MPS or hydrogen peroxide solution successfully.
Exclusion Criteria:
- had a confirmed diagnosis of Sjögren's syndrome or other condition that results in a chronic and/or pathologic dry eye condition;
- required concurrent ocular medication or have used ocular medication within 24 hours of entering the study;
- had a known sensitivity or intolerance to any MPS, study products or ingredient(s);
- were currently participating in any other clinical study;
- had a condition or are in a situation that, in the investigator's opinion, may put them at significant risk, confound the study results, or interfere significantly with their participation in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Biotrue MPS
|
Multi-purpose contact lens care solution
|
EXPERIMENTAL: Investigational MPS
|
Multi-purpose contact lens care solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Corneal Staining by Wear Time
Time Frame: 1 hour on Day 1, 2 hours on Day 2, 4 hours on Day 3 and End of Day on Day 4
|
All participants were contact lenses wearers and were evaluated with a Corneal Staining at 1 hour, 2 hours, 4 hours and end of day.
The corneal staining test is performed using fluorescein drops in the eye and ultraviolet illumination to determine if there has been any damage to the cornea from the use of the lens solutions or from the use of the contact lens.
|
1 hour on Day 1, 2 hours on Day 2, 4 hours on Day 3 and End of Day on Day 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective Solution Preference
Time Frame: Day 4
|
All subjects were asked which solution they prefer based on comfort level: Biotrue MPS, Investigational MPS, or no difference.
|
Day 4
|
Overall Ocular Comfort
Time Frame: Day 4
|
All subjects were asked to rate their lens comfort at each visit based on an 11 point scale where 0 meant that the lens could not be tolerated and 10 indicated that the lens could not be felt.
|
Day 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eugenia Y Kao, OD, AMO
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (ACTUAL)
November 1, 2010
Study Completion (ACTUAL)
November 1, 2010
Study Registration Dates
First Submitted
November 8, 2010
First Submitted That Met QC Criteria
November 10, 2010
First Posted (ESTIMATE)
November 15, 2010
Study Record Updates
Last Update Posted (ACTUAL)
February 6, 2018
Last Update Submitted That Met QC Criteria
January 10, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- COBR-109-9608
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Staining
-
Coopervision, Inc.CompletedCorneal StainingUnited States
-
Alcon ResearchCompleted
-
Innovative MedicalCompletedCorneal StainingUnited States
-
Innovative MedicalCompletedCorneal StainingUnited States
-
Andrasko, Gary, OD, LLCAlcon ResearchUnknownCorneal Staining | Corneal Epithelial DisruptionUnited States
-
Southern California College of Optometry at Marshall...CompletedContact Lens-induced Corneal Fluorescein StainingUnited States
-
Alcon ResearchCompletedCorneal StainingUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual Acuity, Slit Lamp Biomicroscopy (Corneal Staining Assessment)United States
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
Clinical Trials on Biotrue MPS
-
Epstein, Arthur B., OD, FAAOAlcon ResearchCompleted
-
Alcon ResearchCompletedMyopia | Hyperopia | Contact Lens Comfort
-
Bausch & Lomb IncorporatedCompleted
-
Abbott Medical OpticsCompletedAstigmatism | Myopia | HyperopiaUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive Errors | MyopiaUnited States
-
Poitiers University HospitalCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Mackay Memorial HospitalSanofi Taiwan Co. LtdRecruiting
-
Assistance Publique - Hôpitaux de ParisTerminated